Prucalopride reduces the number of reflux episodes and improves subjective symptoms in gastroesophageal reflux disease: a case series

INTRODUCTION: Treatment of persistence to proton pump inhibitors or non-acid reflux episodes in patients with gastroesophageal reflux disease is challenging. Prucalopride, a selective high affinity serotonin (5-HT(4)) receptor agonist, might offer a possible new therapeutic alterative. CASE PRESENTA...

Descripción completa

Detalles Bibliográficos
Autores principales: Nennstiel, Simon, Bajbouj, Monther, Schmid, Roland M, Becker, Valentin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923556/
https://www.ncbi.nlm.nih.gov/pubmed/24502186
http://dx.doi.org/10.1186/1752-1947-8-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923556/
https://www.ncbi.nlm.nih.gov/pubmed/24502186
http://dx.doi.org/10.1186/1752-1947-8-34

Ejemplares similares